Ultragenyx Pharmaceutical (RARE) Capital Expenditures (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Capital Expenditures of $1 million for Q2 2026, down 66.7% from $3 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Capital Expenditures (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ultragenyx Pharmaceutical's Capital Expenditures came in at $4 million, down 30.8% year-over-year; for FY2025, it came in at $6 million, down 14.3% from FY2024.
- Capital Expenditures has declined for three consecutive years, with a five-year compound annual growth rate of -32.8% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $7 million in FY2024 (-84.1%), $44 million in FY2023 (-62.1%), $116.12 million in FY2022 (+58.9%) and $73.09 million in FY2021 (+66.5%).
- Five-year quarterly Capital Expenditures spans a low of $163,000 in Q4 2024 and a high of $32.18 million in Q1 2022.
- Year over year, Capital Expenditures gained in two of the last eight quarters, with growth averaging 26.4%.
- The high point for year-over-year Capital Expenditures in five years was Q4 2025 (growth of 475.5%); the low point was Q4 2023 (a decline of 95.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1 million (Q1 2026), $938,000 (Q4 2025) and $1.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 938,000.00 |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 163,000.00 |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 3.21 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 3.70 Mn |
| Jun 30, 2023 | 13.94 Mn |
| Mar 31, 2023 | 25.03 Mn |
| Dec 31, 2022 | 26.97 Mn |
| Sep 30, 2022 | 26.05 Mn |
| Jun 30, 2022 | 30.92 Mn |
| Mar 31, 2022 | 32.18 Mn |
| Dec 31, 2021 | 16.05 Mn |
| Sep 30, 2021 | 20.56 Mn |
API Access
Ultragenyx Pharmaceutical Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();